Le Lézard
Classified in: Science and technology
Subjects: CCA, FVT

Limelight Networks to Report First Quarter 2021 Financial Results on April 29, 2021


SCOTTSDALE, Ariz., April 1, 2021 /PRNewswire/ -- Limelight Networks, Inc. (NASDAQ: LLNW) will report financial results for the first quarter 2021 on Thursday, April 29, 2021 at 4:00 p.m. EDT (1:00 p.m. PDT). 

Management will host a conference call for investors at 4:30 p.m. EDT (1:30 p.m. PDT). Investors can access this call toll-free at (877) 296-5190 within the United States or +1 (412) 317-5233 outside of the United States.

The conference call will also be audio cast live from http://investors.limelight.com and a replay will be available following the call from the Company's website.

About Limelight:

Limelight Networks, Inc. is an industry-leader in edge access and content delivery services that provides powerful tools and a customer-first approach to optimize and deliver digital experiences at the edge. We are a trusted partner to the world's biggest brands and serve their global customers with experiences such as livestream sporting events, global movie launches, video games or file downloads for new phone apps. Limelight offers one of the largest, best-optimized private networks coupled with a global team of industry experts to provide edge services that are fast, secure and reliable.  For more information, visit www.limelight.com, follow us on Twitter, Facebook and LinkedIn.

SOURCE Limelight Networks


These press releases may also interest you

at 08:05
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the launch of PEMRYDI RTU®, the first and only ready-to-use presentation of pemetrexed for injection. This product does not require reconstitution, dilution, or refrigeration,...

at 08:05
MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the first all-in-one, validated genetic stability assay of its kind. The Aptegratm CHO genetic stability assay leverages whole genome sequencing and...

at 08:05
SugarCRM Wins Gold Stevie Award in the 2024 Sales & Customer Service Awards for CRM Suite, Midmarket, New Version
SugarCRM, provider of the award-winning AI-driven sales automation platform, today announced the company's latest technology accolade ? a Gold Stevie® Award in the CRM Suite, Midmarket, New Version category in the 18th annual Stevie Awards for Sales...

at 08:05
MATRIXX Software to Speak at Linux Foundation ONE Summit
MATRIXX Software, a global leader in 5G and digital monetization solutions, today announced that Olivier Smith, director, office of the CTO, will be speaking at the Linux Foundation (LF) ONE Summit North America. The session, titled "Evolving...

at 08:05
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International, Inc. announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing. The initiative aims to drive the new...

at 08:05
VBI Vaccines Reports Full Year 2023 Financial Results
VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the year ended December 31, 2023. "Over...

More news about Science and technology...


News published on and distributed by: